| Pediatric physiology in relation to the pharmacokinetics of monoclonal antibodies P Malik, A Edginton Expert opinion on drug metabolism & toxicology 14 (6), 585-599, 2018 | 51 | 2018 |
| Biodistribution and physiologically-based pharmacokinetic modeling of gold nanoparticles in mice with interspecies extrapolation M Aborig, PRV Malik, S Nambiar, P Chelle, J Darko, A Mutsaers, ... Pharmaceutics 11 (4), 179, 2019 | 43 | 2019 |
| Pharmacokinetic considerations for antibody-drug conjugates against cancer P Malik, C Phipps, A Edginton, J Blay Pharmaceutical research 34, 2579-2595, 2017 | 43 | 2017 |
| Physiologically‐based pharmacokinetic modeling vs. allometric scaling for the prediction of infliximab pharmacokinetics in pediatric patients PRV Malik, AN Edginton CPT: Pharmacometrics & Systems Pharmacology 8 (11), 835-844, 2019 | 41 | 2019 |
| Predicting escitalopram exposure to breastfeeding infants: integrating analytical and in silico techniques SR Delaney, PRV Malik, C Stefan, AN Edginton, DA Colantonio, S Ito Clinical Pharmacokinetics 57, 1603-1611, 2018 | 39 | 2018 |
| Quantifying breast milk intake by term and preterm infants for input into paediatric physiologically based pharmacokinetic models CHT Yeung, S Fong, PRV Malik, AN Edginton Maternal & child nutrition 16 (2), e12938, 2020 | 38 | 2020 |
| Population PBPK modelling of trastuzumab: a framework for quantifying and predicting inter-individual variability PRV Malik, A Hamadeh, C Phipps, AN Edginton Journal of pharmacokinetics and pharmacodynamics 44, 277-290, 2017 | 31 | 2017 |
| A physiological approach to pharmacokinetics in chronic kidney disease PRV Malik, CHT Yeung, S Ismaeil, U Advani, S Djie, AN Edginton The Journal of Clinical Pharmacology 60, S52-S62, 2020 | 25 | 2020 |
| Integration of ontogeny into a physiologically based pharmacokinetic model for monoclonal antibodies in premature infants PRV Malik, AN Edginton The Journal of Clinical Pharmacology 60 (4), 466-476, 2020 | 25 | 2020 |
| Pediatric dose selection for therapeutic proteins PRV Malik, ZH Temrikar, P Chelle, AN Edginton, B Meibohm The Journal of Clinical Pharmacology 61, S193-S206, 2021 | 11 | 2021 |
| Cariprazine in pediatric patients with autism spectrum disorder: results of a pharmacokinetic, safety and tolerability study PP Yeung, KA Johnson, R Riesenberg, A Orejudos, T Riccobene, ... Journal of Child and Adolescent Psychopharmacology 33 (6), 232-242, 2023 | 7 | 2023 |
| Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation. Pharmaceutics, 2019. 11 (4) M Aborig, PRV Malik, S Nambiar, P Chelle, J Darko, A Mutsaers, ... | 5 | |
| Pharmacists’ knowledge, perceptions and practices regarding frailty: a cross-sectional survey across practice settings in Canada P Malik, N Nakhla, Y Guo, M Tadrous, A Duqoum, DB Hogan, CJ Maxwell Canadian Pharmacists Journal/Revue des Pharmaciens du Canada 156 (3), 159-171, 2023 | 4 | 2023 |
| An infographic assignment to translate self-care therapeutics into practical application P Malik, N Nakhla INNOVATIONS in pharmacy 11 (1), 2020 | 4 | 2020 |
| Determining the effects of chronic kidney disease on organic anion Transporter1/3 activity through physiologically based pharmacokinetic modeling S Dubinsky, P Malik, DM Hajducek, A Edginton Clinical Pharmacokinetics 61 (7), 997-1012, 2022 | 3 | 2022 |
| Instructor-blinded study of Pharmacy Student Learning when a flipped Online Classroom was implemented during the COVID-19 pandemic PRV Malik, N Nakhla Pharmacy 10 (3), 53, 2022 | 2 | 2022 |
| Model-based assessment of the contribution of monocytes and macrophages to the pharmacokinetics of monoclonal antibodies PRV Malik, A Hamadeh, AN Edginton Pharmaceutical Research 39 (2), 239-250, 2022 | 2 | 2022 |
| Skin pharmacokinetics of miltefosine in the treatment of post-kala-azar dermal leishmaniasis in South Asia S Palić, WY Chu, S Sundar, D Mondal, P Das, K Pandey, S Raja, S Rijal, ... Journal of Antimicrobial Chemotherapy, dkae129, 2024 | 1 | 2024 |
| Safety, Tolerability, and Pharmacokinetics of Cariprazine in Pediatric Patients With ASD P Yeung, KA Johnson, R Riesenberg, A Orejudos, T Riccobene, ... AACAP/CACAP 2022 Annual Meeting, 2022 | 1 | 2022 |
| Drug monitoring and physiologically-based pharmacokinetic modeling of escitalopram in breast milk: predicting plasma exposure in breast-feeding infants S Delaney, P Malik, M Takeuchi, E Wong, C Stefan, A Edginton, ... BIRTH DEFECTS RESEARCH 109 (9), 704-704, 2017 | 1 | 2017 |
Pierre ChellePost doctoral fellow, School of Pharmacy, University of WaterlooVerified email at uwaterloo.ca
